48 January 2020 Tablets & Capsules
supplier
news
Catalent, Ethicann to develop
CBD treatment for MS spasticity
SOM ER SE T, NJ — Catalent, a
pharmaceutical CDMO, has part-
nered with Ethicann Pharmaceuticals,
a Calgary-based pharmaceutical com-
pany, to develop a combination phar-
maceutical-grade cannabidiol (CBD)
and tetrahydrocannabinol (THC)
product to treat patients suffering
from multiple sclerosis (MS) spas-
ticity. If approved, the product will
use Catalent's Zydis orally disinte-
grating tablet platform and Ethicann's
botanically-sourced cannabinoid oils.
The companies plan to work on other
cannabinoid-based products in the
future, including a combination of
THC and CBD to treat chemother-
apy-induced nausea and vomiting,
chronic pain, post-traumatic stress
disorder, and opioid mitigation.
Hermes awarded metal
for sustainability
PULLACH, Germany—EcoVadis,
an international rating agency, has
awarded Hermes Pharma, a CDMO
specializing in user-f riendly oral
dosage forms, a silver medal for its
commitment to cor porate social
responsibility (CSR) and sustainabil-
ity initiatives. The agency analyzes
more than 45,000 companies in 190
industry sectors and 150 countries
annually to assess how they integrate
CSR principles into their business
and management systems.
Thermo Fisher expands API
manufacturing capabilities
CORK, Ireland— Thermo Fisher
Scientific has acquired GlaxoSmith-
K line's facilit y in Cork, Ireland,
allowing the CDMO to expand its
API manufacturing capabilities. The
site's 400 employees will become
part of Thermo Fisher's Pharma Ser-
vices A PI business. T he CDMO
will use the Cork team's expertise to
develop novel synthetic processes
and help customers scale up pro-
duction from clinical development
GCP Audits – Best Practices for
Ensuring Compliance & Detecting
Fraud and Misconduct in Clinical
Trials. March 19-20 in Malvern, PA.
Conducted by Center for Professional
Innovation & Education (www.cfpie.
com, 610 648 7550).
DCAT Week. March 23-26 in New
York, NY. Conducted by the Drug,
Chemical, & Associated Technologies
Association (www.dcatweek.org, 609
208 1888).
Pharmaceutical GMP Audits and
Self-Inspections. March 23-27 in
Manchester, UK. Conducted by NSF
(www.nsf.org, 734 769 8010).
GMPs for OTC & Cosmetic Prod-
ucts–US and Global Requirements.
March 25-26 in Malvern, PA. Con-
ducted by Center for Professional
Innovation & Education (www.cfpie.
com, 610 648 7550).
ISPE Europe Annual Conference.
March 30-April 2 in Madrid, Spain.
Conducted by International Society
for Pharmaceutical Engineers (www.
ispe.org, 301 364 9201).
Drug Delivery Partnerships. March
30-April 1 in Orlando, FL. Conducted
by Informa (informaconnect.com /
ddp/, 888 670 8200).
Pharmaceutical Quality Systems-QP
Module. March 30-April 2 in York,
UK. Conducted by NSF (www.nsf.
org, 734 769 8010).
EyeforPharma March 31-Apr il 2
in Barcelona, Spain. Conducted by
Reuters Events (www.eyeforpharma.
com/barcelona, jmackintosh@eyefor
pharma.com).
Gravity Flow & Storage of Bulk Sol-
ids. March 31-April 2 in Salina, KS.
Conducted by K-State Bulk Solids
Innovation Center. (www.bulk-solids.
k-state.edu, 855 552 0079).
Tablet Coating. March 31-April 2
in Binzen, Germany. Conducted by
Technology Training Center (www.
ttc-binzen.de, +49 7621 664 308).
Formulation and Processing Part 2–
QP Module. March 9-13 in London,
UK. Conducted by NSF (www.nsf.
org, 734 769 8010).
Technical Writing for Pharma, Bio-
tech and Med Devices. March 11-13 in
Dublin, Ireland. Conducted by Center
for Professional Innovation & Educa-
tion (www.cfpie.com, 610 648 7550).
Intro to Tablet Press Operations.
March 12 in Cypress, CA. Conducted
by Natoli Service Center (natoli.com,
636 926 8900).
CPhI Japan. March 16-18 in Tokyo,
Japan. Conducted by Informa (www.
cphi.com/japan, +31 207 081 637).
Pharmaceutical GMP Audits and
Self-Inspections. March 16-20 in Ann
Arbor, MI. Conducted by NSF (www.
nsf.org, 734 769 8010).
Pharmaceutical Legislation Update.
March 17 in Manchester, UK. Con-
ducted by NSF (www.nsf.org, 734 769
8010).
Defects Resolution & Problem Solv-
ing. March 17-19 in Cleveland, OH.
Conducted by Techceuticals (www.
techceuticals.com, 216 658 8038).
Pharmaceutical GMP. March 17-19 in
Amsterdam, Netherlands. Conducted
by NSF (www.nsf.org, 734 769 8010).
Regulatory Affairs for QA: Mar-
keting Authorisations. March 18 in
Manchester, UK. Conducted by NSF
(www.nsf.org, 734 769 8010).
Basics of Tablet Press Operations &
Tooling. March 18-19 in Pilchowo,
Poland. Conducted by Natoli Service
Center (natoli.com, 636 926 8900).
Pharmaceutical Legislation Update.
March 19 in Amsterdam, Netherlands.
Conducted by NSF (www.nsf.org, 734
769 8010).
Regulatory Affairs for QA: Varia-
tions. March 19 in Manchester, UK.
Conducted by NSF (www.nsf.org, 734
769 8010).
FDA Inspections–What Regulators
Expect and How to Prepare. March
19-20 in Malvern, PA. Conducted by
Center for Professional Innovation &
Education (www.cfpie.com, 610 648
7550).